Spravato (esketamine) Treatment

Join us for upcoming events, from community gatherings to special sales. We can't wait to see you there. When traditional antidepressants haven’t provided the relief you need, Spravato® (esketamine) may offer a different approach. Spravato works differently from conventional antidepressants by targeting the brain’s glutamate system and NMDA receptors, rather than primarily acting on serotonin or norepinephrine. This unique mechanism may help promote changes in brain connectivity and support the brain’s ability to adapt and form new pathways. For appropriately selected adults with treatment-resistant depression (TRD), Spravato can provide another evidence-based treatment option when standard medications alone have not been enough. Treatment is administered in a controlled clinical setting with monitoring by trained healthcare professionals, allowing you to pursue meaningful improvement with a treatment plan tailored to your individual needs.